中华检验医学杂志
中華檢驗醫學雜誌
중화검험의학잡지
CHINESE JOURNAL OF LABORATORY MEDICINE
2013年
9期
823-827
,共5页
石淙%简正伟%江梅%闻芳%刘淑媛%杨江慧%徐群飞%张长林%万腊根
石淙%簡正偉%江梅%聞芳%劉淑媛%楊江慧%徐群飛%張長林%萬臘根
석종%간정위%강매%문방%류숙원%양강혜%서군비%장장림%만석근
聚合酶链反应%多态性,限制性片段长度%融合蛋白质类,bcr-abl
聚閤酶鏈反應%多態性,限製性片段長度%融閤蛋白質類,bcr-abl
취합매련반응%다태성,한제성편단장도%융합단백질류,bcr-abl
Polymerase chain reaction%Polymorphism,restriction fragment length%Fusion proteins,bcr-abl
目的 建立聚合酶链反应限制性片段长度多态性(PCR-RFLP)联合等位基因特异性聚合酶链反应(AS-PCR)检测bcr/abl融合基因T315I点突变的方法,以提高bcr/abl基因T315I突变检出率.方法 方法学建立.构建abl基因野生型和T315I突变型重组质粒作为检测对象,设计一对野生型和突变型abl基因序列的通用引物,分别以野生型和T315I突变型质粒作为模板,PCR扩增出目的片段,经酶切初筛检测abl基因T315I突变情况,另设计一对仅针对T315I突变的特异性引物进行AS-PCR检测.并对具有该基因突变的1例慢性粒细胞白血病患者进行检测,同时对该方法的灵敏度和特异性进行检测.结果 PCR扩增的目的片段(273 bp)经限制性内切酶Dde Ⅰ酶切后,野生型abl基因片段产生141、68、46和18 bp4条片段,而T315I突变型abl基因片段酶切后产生159、68和46 bp3条片段.PCR-RFLP方法可以检测T315I突变,检测灵敏度为6%.再以酶切产物作为模板进行AS-PCR,优化反应条件,AS-PCR所能检测到的T315I最低突变浓度为0.18%.所测临床标本结果显示,该患者发生了bcr/abl融合基因T315I突变.结论 PCR-RFLP联合AS-PCR检测方法特异性好、灵敏度高,能够给临床检测abl基因T315I突变提供一种新型的检测方法.
目的 建立聚閤酶鏈反應限製性片段長度多態性(PCR-RFLP)聯閤等位基因特異性聚閤酶鏈反應(AS-PCR)檢測bcr/abl融閤基因T315I點突變的方法,以提高bcr/abl基因T315I突變檢齣率.方法 方法學建立.構建abl基因野生型和T315I突變型重組質粒作為檢測對象,設計一對野生型和突變型abl基因序列的通用引物,分彆以野生型和T315I突變型質粒作為模闆,PCR擴增齣目的片段,經酶切初篩檢測abl基因T315I突變情況,另設計一對僅針對T315I突變的特異性引物進行AS-PCR檢測.併對具有該基因突變的1例慢性粒細胞白血病患者進行檢測,同時對該方法的靈敏度和特異性進行檢測.結果 PCR擴增的目的片段(273 bp)經限製性內切酶Dde Ⅰ酶切後,野生型abl基因片段產生141、68、46和18 bp4條片段,而T315I突變型abl基因片段酶切後產生159、68和46 bp3條片段.PCR-RFLP方法可以檢測T315I突變,檢測靈敏度為6%.再以酶切產物作為模闆進行AS-PCR,優化反應條件,AS-PCR所能檢測到的T315I最低突變濃度為0.18%.所測臨床標本結果顯示,該患者髮生瞭bcr/abl融閤基因T315I突變.結論 PCR-RFLP聯閤AS-PCR檢測方法特異性好、靈敏度高,能夠給臨床檢測abl基因T315I突變提供一種新型的檢測方法.
목적 건립취합매련반응한제성편단장도다태성(PCR-RFLP)연합등위기인특이성취합매련반응(AS-PCR)검측bcr/abl융합기인T315I점돌변적방법,이제고bcr/abl기인T315I돌변검출솔.방법 방법학건립.구건abl기인야생형화T315I돌변형중조질립작위검측대상,설계일대야생형화돌변형abl기인서렬적통용인물,분별이야생형화T315I돌변형질립작위모판,PCR확증출목적편단,경매절초사검측abl기인T315I돌변정황,령설계일대부침대T315I돌변적특이성인물진행AS-PCR검측.병대구유해기인돌변적1례만성립세포백혈병환자진행검측,동시대해방법적령민도화특이성진행검측.결과 PCR확증적목적편단(273 bp)경한제성내절매Dde Ⅰ매절후,야생형abl기인편단산생141、68、46화18 bp4조편단,이T315I돌변형abl기인편단매절후산생159、68화46 bp3조편단.PCR-RFLP방법가이검측T315I돌변,검측령민도위6%.재이매절산물작위모판진행AS-PCR,우화반응조건,AS-PCR소능검측도적T315I최저돌변농도위0.18%.소측림상표본결과현시,해환자발생료bcr/abl융합기인T315I돌변.결론 PCR-RFLP연합AS-PCR검측방법특이성호、령민도고,능구급림상검측abl기인T315I돌변제공일충신형적검측방법.
Objective To develop a appropriate assay for identifying T315I point mutation of BCR/ABL fusion gene by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) followed mutant enriched allele specific (AS)-PCR,and to improve screening sentivity of BCR/ABL gene T315I mutant.Methods Recommbinant plasmids harboring wild-type ABL gene and the T315I mutant were constructed respectively and used as the detection objects.A pair of universal primers was designed according to wild-type and T315I mutant gene sequence.The wild-type and T315I mutant plasmids were served as template,the screening of ABL gene T315I mutation was carried out by RFLP after PCR amplification.The AS-PCR for T315I mutation detection was established based on a pair of specific primer.The method was used to detect the status of T315I gene mutation in one patient with chronic myeloid leukemia (CML).Also,the specificity and sensitivity of this method were evaluated.Results The PCR amplicons of the target 273 bp were digested into 4 fragments,141 bp,68 bp,46 bp and 18 bp in the wildtype BCR/ABL fragment and 3 fragments,159 bp,68 bp and 46 bp in the T315I mutant ABL fragment.The sensitivity of PCR-RFLP for the mutation detection of T315I was 6%.The digested production was used as the template in the following AS-PCR reaction through optimizes the reaction condition.The lowest concentration the T315I mutant can by detected by AS-PCR was 0.18%.The result confirmed the presence of T315I gene mutation in the CML patient.Conclusions The PCR-RFLP followed AS-PCR method used in the mutation detection in this study has higher specificity and sensitivity,providing a new qualitative tool for ABL gene T315I mutation detection.